Cargando…
Metabolomics-Guided Hypothesis Generation for Mechanisms of Intestinal Protection by Live Biotherapeutic Products
The use of live biotherapeutic products (LBPs), including single strains of beneficial probiotic bacteria or consortiums, is gaining traction as a viable option to treat inflammatory-mediated diseases like inflammatory bowel disease (IBD). However, LBPs’ persistence in the intestine is heterogeneous...
Autores principales: | Ye, Jiayu, Erland, Lauren A. E., Gill, Sandeep K., Bishop, Stephanie L., Verdugo-Meza, Andrea, Murch, Susan J., Gibson, Deanna L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156236/ https://www.ncbi.nlm.nih.gov/pubmed/34063522 http://dx.doi.org/10.3390/biom11050738 |
Ejemplares similares
-
The Morphoregulatory Role of Thidiazuron: Metabolomics-Guided Hypothesis Generation for Mechanisms of Activity
por: Erland, Lauren A. E., et al.
Publicado: (2020) -
A49 TWO NOVEL LIVE BIOTHERAPEUTIC PRODUCTS PROTECT DSS-EXPOSED MICE FROM ACUTE COLITIS WHEN COMPARED TO 5-ASA
por: Verdugo Meza, A, et al.
Publicado: (2023) -
Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites
por: Verdugo-Meza, Andrea, et al.
Publicado: (2020) -
Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
por: Martin, Kyle P., et al.
Publicado: (2023) -
Editorial: Synthetic Live Biotherapeutic Products for Diseases
por: Chen, Ye, et al.
Publicado: (2022)